Evidence map›Paper›PMID 32660176›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2020

[Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].

Z H Zhou, X G Zhou, Z W Zhou, M Q Qiu, Y J Jiang, Q L Lin, Y C Liu, Q P Wen, R R Huo, X M Liang and 1 more

Open access · greenAbstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Z H ZhouGuangxi Medical University Cancer Hospital, Nanning 530021, China; School of Public Health, Guangxi Medical University, Nanning 530021, China.
X G ZhouGuangxi Medical University Cancer Hospital, Nanning 530021, China.
Z W ZhouSchool of Public Health, Guangxi Medical University, Nanning 530021, China.
M Q QiuSchool of Public Health, Guangxi Medical University, Nanning 530021, China.
Y J JiangSchool of Public Health, Guangxi Medical University, Nanning 530021, China.
Q L LinSchool of Public Health, Guangxi Medical University, Nanning 530021, China.
Y C LiuGuangxi Medical University Cancer Hospital, Nanning 530021, China.
Q P WenGuangxi Medical University Cancer Hospital, Nanning 530021, China.
R R HuoGuangxi Medical University Cancer Hospital, Nanning 530021, China.
X M LiangGuangxi Medical University Cancer Hospital, Nanning 530021, China.
H P YuGuangxi Medical University Cancer Hospital, Nanning 530021, China.
Guangxi Medical University · CN

Funding

National Natural Science Foundation of China 81660567Natural Science Foundation of Guangxi Province of China 2019JJA140102
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingDNA MethylationGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMicroRNAsTranscriptomeMicroRNAsRNA, Long NoncodingDNA methylationHepatocelluar carcinomaPrognosis

Identifiers

PMID32660176
PMCPMC12769070
OpenAlexW3043738172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.